Correction to: Large‑scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease

Affiliations

• ¹ Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.
• ² Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA.
• ³ Fundació Docència i Recerca Mútua Terrassa and Movement Disorders Unit, Department of Neurology, University Hospital Mútua Terrassa, Terrassa, 08221, Barcelona, Spain.
• ⁴ Departamento de Ingeniería de la Información y las Comunicaciones, Universidad de Murcia, Murcia, Spain.
• ⁵ Department of Molecular Neuroscience, UCL, Institute of Neurology, London, UK.
• ⁶ Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, London, UK.
• ⁷ Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.
• ⁸ Montreal Neurological Institute, McGill University, Montréal, QC, Canada.
• ⁹ Department of Human Genetics, McGill University, Montréal, QC, Canada.
• ¹⁰ Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London and Department of Neurology, Royal London Hospital, London, UK.
• ¹¹ Department of Neurology, Oslo University Hospital, Oslo, Norway.
• ¹² The Scripps Research Institute, La Jolla, CA, 92037, USA.
• ¹³ The American Genome Center, Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MA, USA.
• ¹⁴ Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, MA, USA.
• ¹⁵ Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, 20892, USA.
• ¹⁶ Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, 21287, USA.
• ¹⁷ Parkinson's Disease Clinic, Office of the Clinical Director, National Institute of Neurological, Disorders and Stroke, National Institutes of Health, Bethesda, MD, 20892, USA.
• ¹⁸ Center for Advanced Parkinson Research, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, 0115, USA.
• ¹⁹ Verily Life Sciences, South San Francisco, CA, USA.
• ²⁰ Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MA, USA.
• ²¹ Data Tecnica International, Glen Echo, MD, 20812, USA.
• ²² Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892, USA. singleta@mail.nih.gov.